Your browser doesn't support javascript.
loading
Mefunidone ameliorates lipopolysaccharide-induced acute lung injury through inhibiting MAPK signaling pathway and enhancing Nrf2 pathway.
Yao, Ting-Ting; Zhang, Yan; He, Rong-Ling; Lv, Xin; He, Yi-Jun; Li, Meng-Yu; Han, Yuan-Yuan; Long, Ling-Zhi; Jiang, Guo-Liang; Cheng, Xiao-Yun; Hu, Gao-Yun; Li, Qian-Bin; Tao, Li-Jian; Meng, Jie.
Afiliación
  • Yao TT; Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
  • Zhang Y; Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
  • He RL; Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
  • Lv X; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China.
  • He YJ; Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
  • Li MY; Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
  • Han YY; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China.
  • Long LZ; Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
  • Jiang GL; Department of Pulmonary and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China.
  • Cheng XY; Department of Pulmonary and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China.
  • Hu GY; Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China; Hunan Key Laboratory of Organ Fibrosis, Changsha, China.
  • Li QB; Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China; Hunan Key Laboratory of Organ Fibrosis, Changsha, China.
  • Tao LJ; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Organ Fibrosis, Changsha, China; National International Collaborative Research Center for Medical Metabolomics, Changsha, China.
  • Meng J; Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Organ Fibrosis, Changsha, China; National International Collaborative Research Center for Medical Metabolomics, Changsha, China. Electronic address: mengjie@
Int Immunopharmacol ; 113(Pt A): 109263, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36334370
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piperazinas / Piridonas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piperazinas / Piridonas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China